Stockreport

Revance beefs up commercial team ahead of launch of Botox competitor RT002 [Seeking Alpha]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF Revance beefs up commercial team ahead of launch of Botox competitor RT002Preparing for the commercial launch of DaxibotulinumtoxinA (RT002) for the treatment of frown l [Read more]